Androgen Signaling Promotes Translation of TMEFF2 in Prostate Cancer Cells via Phosphorylation of the α Subunit of the Translation Initiation Factor 2

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Overcash, Ryan F ^a   Chappell, Vesna A ^a   Green, Thomas ^a   Geyer, Christopher B ^a   Asch, Adam S ^a,b   Ruiz Echevarría, Maria J ^a,b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; HYBRID PROTEIN; INITIATION FACTOR 2ALPHA; LUCIFERASE; MESSENGER RNA; SMALL INTERFERING RNA; TUMOR PROTEIN; TYPE I TRANSMEMBRANE PROTEIN WITH EPIDERMAL GROWTH FACTOR AND TWO FOLLISTATIN MOTIF 2 PROTEIN; UNCLASSIFIED DRUG; 5' UNTRANSLATED REGION; INITIATION FACTOR 2; MEMBRANE PROTEIN; PROTEIN SUBUNIT; TMEFF2 PROTEIN, HUMAN;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBRYO; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC CODE; HORMONAL REGULATION; MALE; MOUSE; NONHUMAN; OPEN READING FRAME; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; TUMOR GENE; TYPE I TRANSMEMBRANE PROTEIN WITH EPIDERMAL GROWTH FACTOR AND TWO FOLLISTATIN MOTIF 2 GENE; UPREGULATION; BIOSYNTHESIS; ENDOPLASMIC RETICULUM; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PROSTATE TUMOR; PROTEIN SUBUNIT; PROTEIN SYNTHESIS; TUMOR CELL LINE;

5' UNTRANSLATED REGIONS; ANDROGENS; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; HUMANS; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; OPEN READING FRAMES; PHOSPHORYLATION; PROKARYOTIC INITIATION FACTOR-2; PROSTATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEIN SUBUNITS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 84873535826     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055257     Document Type: Article

References (65)

1. Heinlein CA, Chang C, (2004) Androgen receptor in prostate cancer. Endocr Rev 25: 276-308.
2. Wang Q, Li W, Zhang Y, Yuan X, Xu K, et al. (2009) Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138: 245-256.
3. Liang T, Liao S, (1975) A very rapid effect of androgen on initiation of protein synthesis in prostate. Proc Natl Acad Sci U S A 72: 706-709.
4. Liang T, Liao S, (1975) Dihydrotestosterone and the initiation of protein synthesis by prostate ribosomes. J Steroid Biochem 6: 549-550.
5. Heanue TA, Pachnis V, (2006) Expression profiling the developing mammalian enteric nervous system identifies marker and candidate hirschsprung disease genes. Proc Natl Acad Sci U S A 103: 6919-6924.
6. Uchida T, Wada K, Akamatsu T, Yonezawa M, Noguchi H, et al. (1999) A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. Biochem Biophys Res Commun 266: 593-602.
7. Afar DE, Bhaskar V, Ibsen E, Breinberg D, Henshall SM, et al. (2004) Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. Mol Cancer Ther 3: 921-932.
8. Gery S, Sawyers CL, Agus DB, Said JW, Koeffler HP, (2002) TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells. Oncogene 21: 4739-4746.
9. Glynne-Jones E, Harper ME, Seery LT, James R, Anglin I, et al. (2001) TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. Int J Cancer 94: 178-184.
10. Mohler JL, Morris TL, Ford OH,3rd, Alvey RF, Sakamoto C, et al (2002) Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer. Prostate 51: 247-255.
11. Chen X, Overcash R, Green T, Hoffman D, Asch AS, et al. (2011) The tumor suppressor activity of the transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) correlates with its ability to modulate sarcosine levels. J Biol Chem 286: 16091-16100.
12. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914.
13. Morris DR, Geballe AP, (2000) Upstream open reading frames as regulators of mRNA translation. Mol Cell Biol 20: 8635-8642.
14. Sudhakar A, Ramachandran A, Ghosh S, Hasnain SE, Kaufman RJ, et al. (2000) Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry 39: 12929-12938.
15. Vattem KM, Wek RC, (2004) Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A 101: 11269-11274.
16. Palam LR, Baird TD, Wek RC, (2011) Phosphorylation of eIF2 facilitates ribosomal bypass of an inhibitory upstream ORF to enhance CHOP translation. J Biol Chem 286: 10939-10949.
17. Scheuner D, Song B, McEwen E, Liu C, Laybutt R, et al. (2001) Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol. Cell 7: 1165-1176.
18. Kim HJ, Park YI, Dong MS, (2006) Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays. Toxicol in Vitro 20: 1159-1167.
19. Esfahani A, Kendall CW, Bashyam B, Archer MC, Jenkins DJ, (2010) The effect of physiological concentrations of sex hormones, insulin, and glucagon on growth of breast and prostate cells supplemented with unmodified human serum. In Vitro Cell Dev Biol Anim 46: 856-862.
20. Baird TD, Wek RC, (2012) Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism. Adv Nutr 3: 307-321.
21. Aktas H, Fluckiger R, Acosta JA, Savage JM, Palakurthi SS, et al. (1998) Depletion of intracellular Ca2+ stores, phosphorylation of eIF2alpha, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole. Proc Natl Acad Sci U S A 95: 8280-8285.
22. Masek T, Valasek L, Pospisek M, (2011) Polysome analysis and RNA purification from sucrose gradients. Methods Mol Biol 703: 293-309.
23. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, et al. (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6: 1099-1108.
24. Bennett NC, Gardiner RA, Hooper JD, Johnson DW, Gobe GC, (2010) Molecular cell biology of androgen receptor signalling. Int J Biochem Cell Biol 42: 813-827.
25. Pascall JC, (1997) Post-transcriptional regulation of gene expression by androgens: Recent observations from the epidermal growth factor gene. J Mol Endocrinol 18: 177-180.
26. Nantermet PV, Xu J, Yu Y, Hodor P, Holder D, et al. (2004) Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. J Biol Chem 279: 1310-1322.
27. El-Awady MK, El-Garf W, El-Houssieny L, (2004) Steroid 5alpha reductase mRNA type 1 is differentially regulated by androgens and glucocorticoids in the rat liver. Endocr J 51: 37-46.
28. Fletcher CE, Dart DA, Sita-Lumsden A, Cheng H, Rennie PS, et al. (2012) Androgen-regulated processing of the oncomir MiR-27a, which targets prohibitin in prostate cancer. Hum Mol Genet 21: 3112-3127.
29. Rajabi H, Joshi MD, Jin C, Ahmad R, Kufe D, (2011) Androgen receptor regulates expression of the MUC1-C oncoprotein in human prostate cancer cells. Prostate 71: 1299-1308.
30. Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, et al. (2008) Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Prostate 68: 1133-1142.
31. Hamdi MM, Mutungi G, (2011) Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2-dependent mechanism. J Physiol 589: 3623-3640.
32. Xu Y, Chen SY, Ross KN, Balk SP, (2006) Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res 66: 7783-7792.
33. Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, et al. (2006) Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol 4: e374.
34. Pavitt GD, Ron D, (2012) New insights into translational regulation in the endoplasmic reticulum unfolded protein response. Cold Spring Harb Perspect Biol 4: a01227810 DOI:10.1101/cshperspect.a012278.
35. Clemens MJ, (2001) Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis. Prog Mol Subcell Biol 27: 57-89.
36. Haren MT, Siddiqui AM, Armbrecht HJ, Kevorkian RT, Kim MJ, et al. (2011) Testosterone modulates gene expression pathways regulating nutrient accumulation, glucose metabolism and protein turnover in mouse skeletal muscle. Int J Androl 34: 55-68.
37. Yoshioka M, Boivin A, Ye P, Labrie F, St-Amand J, (2006) Effects of dihydrotestosterone on skeletal muscle transcriptome in mice measured by serial analysis of gene expression. J Mol Endocrinol 36: 247-259.
38. Dai R, Yan D, Li J, Chen S, Liu Y, et al. (2012) Activation of PKR/eIF2alpha signaling cascade is associated with dihydrotestosterone-induced cell cycle arrest and apoptosis in human liver cells. J Cell Biochem 113: 1800-1808.
39. Liu S, Navarro G, Mauvais-Jarvis F, (2010) Androgen excess produces systemic oxidative stress and predisposes to beta-cell failure in female mice. PLoS One 5: e11302.
40. Ripple MO, Hagopian K, Oberley TD, Schatten H, Weindruch R, (1999) Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications. Antioxid Redox Signal 1: 71-81.
41. Sun XY, Donald SP, Phang JM, (2001) Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells. Carcinogenesis 22: 1775-1780.
42. Mehraein-Ghomi F, Lee E, Church DR, Thompson TA, Basu HS, et al. (2008) JunD mediates androgen-induced oxidative stress in androgen dependent LNCaP human prostate cancer cells. Prostate 68: 924-934.
43. Lozon TI, Eastman AJ, Matute-Bello G, Chen P, Hallstrand TS, et al. (2011) PKR-dependent CHOP induction limits hyperoxia-induced lung injury. Am J Physiol Lung Cell Mol Physiol 300: L422-L429.
44. Foradori CD, Weiser MJ, Handa RJ, (2008) Non-genomic actions of androgens. Front Neuroendocrinol 29: 169-181.
45. Srivastava SP, Davies MV, Kaufman RJ, (1995) Calcium depletion from the endoplasmic reticulum activates the double-stranded RNA-dependent protein kinase (PKR) to inhibit protein synthesis. J Biol Chem 270: 16619-16624.
46. Pan C, Giraldo GS, Prentice H, Wu JY, (2010) Taurine protection of PC12 cells against endoplasmic reticulum stress induced by oxidative stress. J Biomed Sci 17Suppl 1: S17 DOI:10.1186/1423-0127-17-S1-S17.
47. Lin K, Taylor JR Jr, Wu TD, Gutierrez J, Elliott JM, et al. (2011) TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma. PLoS One 6: e18608.
48. Juntti SA, Tollkuhn J, Wu MV, Fraser EJ, Soderborg T, et al. (2010) The androgen receptor governs the execution, but not programming, of male sexual and territorial behaviors. Neuron 66: 260-272.
49. Lonergan PE, Tindall DJ, (2011) Androgen receptor signaling in prostate cancer development and progression. J Carcinog 10: 20 DOI:10.4103/1477-3163.83937.
50. Chen TR, Wang P, Carroll LK, Zhang YJ, Han BX, Wang F, (2012) Generation and characterization of Tmeff2 mutant mice. Biochem Biophys Res Commun 425: 189-194.
51. Kumarasamy S, Gopalakrishnan K, Toland EJ, Yerga-Woolwine S, Farms P, et al. (2011) Refined mapping of blood pressure quantitative trait loci using congenic strains developed from two genetically hypertensive rat models. Hypertension Res 34: 1263-1270.
52. Lizotte E, Grandy SA, Tremblay A, Allen BG, Fiset C, (2009) Expression, distribution and regulation of sex steroid hormone receptors in mouse heart. Cell Physiol Biochem. 23: 75-86.
53. Pausova Z, Abrahamowicz M, Mahboubi A, Syme C, Leonard GT, et al. (2010) Functional variation in the androgen-receptor gene is associated with visceral adiposity and blood pressure in male adolescents. Hypertension 55: 706-714.
54. Ikeda Y, Aihara K, Yoshida S, Akaike M, Matsumoto T, (2012) Effects of androgens on cardiovascular remodeling. J Endocrinol 214: 1-10.
55. Floryk D, Kurosaka S, Tanimoto R, Yang G, Goltsov A, et al. (2011) Castration-induced changes in mouse epididymal white adipose tissue. Mol Cell Endocrinol 345: 58-67.
56. Quinkler M, Bujalska IJ, Kaur K, Onyimba CU, Buhner S, et al. (2005) Androgen Receptor-Mediated Regulation of the α-Subunit of the Epithelial Sodium Channel in Human Kidney. Hypertension 46: 787-798.
57. Cuesta R, Gupta M, Schneider RJ, (2009) The regulation of protein synthesis in cancer. Prog Mol Biol Transl Sci 90: 255-292.
58. Silvera D, Formenti SC, Schneider RJ, (2010) Translational control in cancer. Nat Rev Cancer 10: 254-266.
59. Mounir Z, Krishnamoorthy JL, Robertson GP, Scheuner D, Kaufman RJ, et al. (2009) Tumor suppression by PTEN requires the activation of the PKR-eIF2alpha phosphorylation pathway. Sci Signal 2: ra85 DOI:10.1126/scisignal.2000389.
60. Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, et al. (2001) A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 61: 4315-4319.
61. Putluri N, Shojaie A, Vasu VT, Nalluri S, Vareed SK, et al. (2011) Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells. PLoS One 6: e21417.
62. Kinoshita H, Shi Y, Sandefur C, Meisner LF, Chang C, et al. (2000) Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Cancer Res 60: 3623-3630.
63. Gaughan L, Stockley J, Wang N, McCracken SRC, Treumann A, et al. (2011) Regulation of the androgen receptor by SET9-mediated methylation. Nucleic Acids Res 39: 1266-1279.
64. Ko S, Ahn J, Song CS, Kim S, Knapczyk-Stwora K, et al. (2011) Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase. Mol Endocrinol 25: 433-444.
65. Zhao JC, Yu J, Runkle C, Wu L, Hu M, et al. (2012) Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Res 22: 322-331.